NL-OMON56128
Recruiting
Not Applicable
Very short-course versus standard course antibiotic therapy in patients with acute ChOlangitis after adequate endoscopic BiliaRy drAinage (COBRA trial). - COBRA
Amsterdam UMC0 sites440 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Amsterdam UMC
- Enrollment
- 440
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Patients with acute cholangitis due to common bile duct stones, benign or
- •malignant distal biliary obstruction or distal biliary stent dysfunction (only
- •stents in situ for a minimum of 30 days)
- •\- ERCP with adequate biliary drainage (all common bile duct stones are removed
- •and/or there is adequate flow of bile with or without a biliary stent(s))
- •\- Age \>\= 18 years
- •\- Written informed consent
Exclusion Criteria
- •\- Other etiologies of acute cholangitis (e.g. primary sclerosing cholangitis,
- •(sub)hilar and/or intrahepatic strictures or hilar stents)
- •\- A recurrent cholangitis (within 3 months)
- •\- Concomitant pancreatitis, cholecystitis or liver abscess
- •\- Another additional infectious diagnosis
- •\- Use of maintenance antimicrobial therapy
- •\- Use of immunosuppressants
- •\- Neutropenia
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Short-course antibiotic regimen compared to conventional antibiotic treatment for gram-positive cocci infective endocarditis: randomized clinical trialinfective endocarditisTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2019-003358-10-ESCarmen Olmos Blanco298
Not yet recruiting
Phase 3
Comparing long and short duration antibiotics for abdominal infectionsHealth Condition 1: null- Complicated Intra-abdominal InfectionsCTRI/2018/03/012682Jawaharlal Institute of PostGraduate Medical Education and Research
Not yet recruiting
Not Applicable
Efficacy of Short-Course vs Long-Course Antibiotic Therapy for Community-Acquired Pneumonia:A Systematic Review and Meta-AnalysisCommunity-acquired pneumoniaJPRN-UMIN000049959Japan Respiratory Society
Active, not recruiting
Phase 1
Short versus extended antibiotic treatment for fever during low white blood cell counts in hematology patients with fever of unknown origin.Febrile neutropeniaMedDRA version: 19.1Level: PTClassification code 10063581Term: Stem cell transplantSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.1Level: LLTClassification code 10002969Term: Aplastic anemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 19.1Level: LLTClassification code 10003999Term: BacteremiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10007810Term: Catheter related infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10028566Term: MyelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10062957Term: Catheter bacteraemiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10025310Term: LymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10024329Term: LeukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: PTClassification code 10056520Term: Catheter site infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10016288Term: Febrile neutropeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2014-001546-25-NLVU University Medical Center240
Completed
Phase 4
Short versus extended antibiotic treatment with a carbapenem for high-risk febrile neutropenia in hematology patients with Fever of Unknown Origin: a randomized multicenter open-label non-inferiority trial.febrile neutropenia1001886510004018NL-OMON47609VUmc276